Recombinant humanized monoclonal antibody to IL-17A.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivité
Human
Hôte
Humanized
Clonalité
Monoclonal
Isotype
IgG4SP - Human IgG4 with S228P mutation
Chaînes légères
kappa
Conjuguer
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Masse moléculaire
This antibody has a predicted MW of 146.44 kDa.
Pureté
> 95% (by SDS-PAGE and SEC-HPLC).
Forme du produit
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Stockage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Ixekizumab Biosimilar - Anti-IL-17A Antibody - Low endotoxin, Azide free (A323522) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Ixekizumab Biosimilar - Anti-IL-17A Antibody - Low endotoxin, Azide free (A323522) confirms that the purity of this antibody is 98.86%.
Produits alternatifs à Anti-IL-17A Anticorps (A323522)